AI filing briefs · archive

8-K filings in April 2024, explained

186 material Form 8-K filings that 173 companies we cover made with the SEC in April 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

1 of 186 briefs matches

newest first · times in ET

BIOBIO-RAD LABORATORIES, INC. Apr 10, 4:16 PM ET

Bio-Rad COO Andrew Last to retire by early September 2024; search for successor underway

Neutral leadership Written later 5.02

Bio-Rad Laboratories' Executive Vice President and Chief Operating Officer, Dr. Andrew Last, notified the company on April 10, 2024 that he plans to retire by early September 2024. He will stay in his current role while Bio-Rad searches for a successor, which the company says is intended to ensure a smooth transition.

Dr. Andrew Last, EVP and Chief Operating Officer, intends to retire by early September 2024
Dr. Last will remain in his current position while the company searches for a successor
Dr. Last joined Bio-Rad in April 2019; CEO Norman Schwartz credited him with cost structure, core process and supply chain improvements

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.